Evidence map›Paper›PMID 34604831›Full record

ArticleComputer methods and programs in biomedicine update2021

Forecasting COVID-19 pandemic in Alberta, Canada using modified ARIMA models.

Jian Sun

Abstract read
In one paragraph

Article in Computer methods and programs in biomedicine update, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jian SunSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesAuto regressive integrated moving average (ARIMA) model is a popular model to forecast future values of a time series using the past values of the same series. However, if the variance of the time series varies with time, the 95% confidence interval estimated by the ARIMA will not be accurate. This study proposes a method to revise the ARIMA model to suit time series with heteroscedasticity.

methodsMultiple historical ARIMA models were constructed with publicly available COVID-19 data in Alberta, Canada. The time series between different time periods were applied for these models. The means and their 95% confidence intervals of the differences between the forecasted values and the corresponding actual values were computed. The forecasted values of the general ARIMA models were modified by adding these differences.

resultsThe average incident cases forecasted with the proposed method are lower than those with a general ARIMA model during the forecasted period. The 95% confidence intervals of the forecasted incidence with the proposed method are narrower. During the forecasted period (13 weeks) the average incidence was predicted to increase first and then decrease exponentially.

conclusionThe proposed method can be used to automatically specify the best ARIMA model, to fit time series with heteroscedasticity and to forecast longer period of the trends in the future. In the next 13 weeks, the Covid-19 incidence may decrease but not eliminate. To stop the transmission of infections eventually, persistent effects complying with accurate forecasts are necessary.

Indexed as

ARIMACOVID-19Infectious diseaseSASTime series analysis

Identifiers

PMID34604831
PMCPMC8466853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.